4.5 Editorial Material

Erythropoietic protoporphyria and afamelanotide: a patient's perspective

Journal

CLINICAL AND EXPERIMENTAL DERMATOLOGY
Volume -, Issue -, Pages -

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ced/llad346

Keywords

-

Categories

Ask authors/readers for more resources

The article discusses the patient's exploration of the profound impact of erythropoietic protoporphyria (EPP) on her life, as well as the clinician's comment on the symptoms, diagnostic criteria, and novel treatment option afamelanotide for EPP.
The patient explores the profound impact of erythropoietic protoporphyria (EPP) on her life to date. The clinician's comment reviews the symptoms and diagnostic criteria for EPP, as well as the novel treatment afamelanotide for EPP.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available